Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- General Virology
-
1. Principles of virology
- Prof. Vincent Racaniello
-
2. The type I interferon system and viruses
- Dr. Adolfo Garcia-Sastre
-
3. Immune responses to viruses
- Prof. Paul Klenerman
- Emerging Pathogens
-
4. Emerging or newly discovered viral causes of acute lower respiratory tract infections worldwide
- Dr. Marietjie Venter
- Mrs. Orienka Hellferscee
-
5. Emerging respiratory viruses - discoveries between 2001 and 2005
- Prof. Ron Fouchier
-
6. Usage of vaccines and therapeutics in public health emergencies 1
- Prof. Gary Kobinger
-
7. Usage of vaccines and therapeutics in public health emergencies 2
- Prof. Gary Kobinger
-
8. Influenza virus pandemics: past and future
- Prof. Peter Palese
-
9. SARS-CoV and other emerging coronaviruses
- Prof. Ralph Baric
-
10. Dengue, Zika and Chickungunya viruses
- Prof. Ana Fernandez-Sesma
-
11. Paramyxoviruses: biology & pathogenesis
- Prof. Benhur Lee
-
12. Antiviral drugs (non-HIV)
- Prof. Megan Shaw
-
13. Biodefense challenges
- Dr. David Franz
- Important Pathogens and their Diseases
-
14. Natural history and pathogenesis of herpes virus infections
- Prof. Richard Whitley
-
15. Cytomegalovirus biology
- Prof. Domenico Tortorella
-
16. Hepatitis C virus: discovery, cure and protection
- Dr. Matthew Evans
-
17. Fundamentals of HIV biology
- Prof. Viviana Simon
-
18. Measles
- Prof. Diane E. Griffin
-
19. Monkeypox virus, vaccines, and therapeutics
- Prof. Rachel Roper
- New Frontiers
-
22. Viruses as anticancer weapons
- Prof. Roberto Cattaneo
-
23. Novel approaches to diagnosis of viral infections
- Prof. W. Ian Lipkin
-
24. The Global Virus Network: collaboration to address pandemic and regional threats
- Prof. Sten H. Vermund
-
25. Elite controllers of HIV: from discovery to future therapies
- Prof. Bruce Walker
- Archived Lectures *These may not cover the latest advances in the field
-
26. Principles of virology I
- Prof. Richard Condit
-
27. Principles of virology II
- Prof. Richard Condit
-
28. Complex DNA viruses: herpes virus
- Dr. John Blaho
-
29. Adeno-associated viruses (AAV)
- Prof. Kenneth Berns
-
30. Poxviruses: smallpox (variola), vaccinia and monkeypox
- Prof. Paula Traktman
-
31. Can HPV testing be the sole primary cervical screening modality?
- Prof. Jack Cuzick
-
32. From viruses to oncolytics
- Prof. Roberto Cattaneo
-
33. Non HIV antivirals
- Prof. Mary Klotman
-
34. Gastroenteritis viruses
- Prof. Mary Estes
-
35. Biodefense challenges
- Dr. Connie Schmaljohn
-
37. The past, present and future of vaccination
- Prof. Stanley Plotkin
-
38. Filoviruses
- Dr. Christopher Basler
-
39. Bunyaviruses
- Prof. Richard Elliott
-
40. The immunobiology of HIV
- Prof. Norman Letvin
-
41. Hepatitis C and HCV
- Prof. Stanley Lemon
Printable Handouts
Navigable Slide Index
- Introduction
- The Global Virus Network (GVN)
- Member declaration: March 2011
- Senior advisors
- GVN mission
- Why GVN
- GVN meets its mission in three ways
- The network
- Virus expertise
- GVN regional headquarters
- Programs and initiatives
- Programs and initiatives overview
- 2024 GVN international annual scientific meeting
- GVN regional meetings
- GVN virtual biobank program
- GVN Drs. Zhang & Liu Academy Program (1)
- GVN Drs. Zhang & Liu Academy Program (2)
- GVN Short Course in Translational Virology
- GVN Short Course in Translational Virology 2023
- Attendee testimonials: Alexandre Borin
- Attendee testimonials: Lea Necitas G. Apostol
- Attendee testimonials: Abdul Azeez Anjorin
- The course
- Online Short-Course in Translational Virology
- GVN Postdoctoral Fellowship Training Program: goal and details
- GVN Postdoctoral Fellowship Training Program
- GVN postdoctoral fellowship training program: William M. Souza
- The GVN – Abbott Pandemic Defense Postdoctoral Fellowship Program
- GVN Rising Stars Program
- GVN Rising Stars discuss their research
- GVN & USF online course
- GVN Alumni Networking Series
- Task Forces and Watch Groups
- Science in action: Task Forces and Watch Groups
- Statistics
- COVID-19 within Respiratory Viruses Watch Group
- Mpox Task Force
- Long-COVID Task Force
- Emerging Pathogens Watch Group
- Arbovirus Watch Group
- Viral Detection and Control Watch Group
- Respiratory Viruses Watch Group
- Hemorrhagic Fever Viruses Watch Group
- Statements and perspectives
- Corporate partners
- GVN Healthcare & Pharma Centers of Excellence Coalition (GHPC)
- GHPC members
- Corporate partnerships activities highlights
- Communication, media and public education
- GVN's information sharing: GVN’s mission
- GVN's information sharing: strategic plan goals
- GVN: Forefront of Virology Webinar Series
- GVN public relations: 2023
- New initiatives
- GVN Strategic Plan
- GVN Strategic Plan (2023-2028)
- GVN’s constellation in the medical virology universe
- In conclusion
- Thank you!
Topics Covered
- The Global Virus Network (GVN)
- GVN mission
- Programs and initiatives
- GVN Drs. Zhang & Liu Academy Program
- GVN courses and programs
- GVN Postdoctoral Fellowship Training Program
- Task Forces and Watch Groups
- GVN Healthcare & Pharma Centers of Excellence Coalition (GHPC)
Links
Series:
- Periodic Reports: Advances in Clinical Interventions and Research Platforms
- Viruses and Viral Diseases
Categories:
Therapeutic Areas:
External Links
Talk Citation
Vermund, S.H. (2024, August 29). The Global Virus Network: collaboration to address pandemic and regional threats [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 11, 2024, from https://doi.org/10.69645/OSVM4786.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Sten H. Vermund has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Immunology
Transcript
Please wait while the transcript is being prepared...
0:00
Hello. Happy to be
with you today.
My name is Sten Vermund.
I serve as President of the
Global Virus Network and I'm
also a professor in
the Yale School of Public Health
in Yale School of Medicine.
Today, we'll talk about
the Global Virus Network
as a collaborative group
addressing pandemic
and regional threats
in the field of viral diseases.
0:28
There's a 13 year history of
the Global Virus Network as
a voluntary consortium
of virus fighters.
We are currently engaged with
78 laboratories and centers
of excellence and
affiliate centers
in 41 countries on
six continents.
0:50
We declared our
utility and mission in
March of 2011 representing
centers of excellence for
research and virology,
dedicated to
understanding, preventing,
and eradicating viral diseases.
We're all about getting
programs to coordinate,
support and promote research.
We're interested in the
public health aspects of
virology including
surveillance and
implementation of programs.
We are trying new
approaches to foster
collaboration across
centers and countries
and continents.
Trying to improve
immediate responses
to emerging viral threats,
training future generations of
virologists, and
advising governments,
policymakers, non-governmental
organizations
on viral disease threats
and their control.
We are seeking to
fill a need to bridge
across nations in
this consultative and
facilitative role.
Hide